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Melatonin’s Effect in Febrile Seizures and Epilepsy
Abstract
Objective
Recognition of risk factors for febrile seizures (FS) and epilepsy is essential. 
Studies regarding the role of melatonin in these convulsive disorders are limited. 
This study determines the relationship between serum melatonin levels and FS 
and epilepsy in children. 
Materials & Methods
A population of 111 children with simple FS, complex FS, and epilepsy (37 
children per group, respectively) were included as case groups. In addition, 37 
febrile children without seizures comprised the control group. Serum melatonin 
levels were measured and compared between all groups.
Results
The serum melatonin levels in the simple, complex FSs, and epilepsy groups 
were 2, 2.4, and 2 pg/ml, respectively. The serum melatonin level in the control 
group was 2.1pg/ml.
Moreover, there were no significant differences observed while comparing the 
case groups.
Conclusion
The present study reveals that there is no association between serum melatonin 
level and simple or complex FS and epilepsy. It appears that melatonin plays no 
significant role in these convulsive disorders.
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ORIGINAL  ARTICLE
Introduction
Febrile seizures (FS) and epilepsy are the most common causes of seizures in 
children (1).The incidence of FS is2−9% (2,3).According to the definitions provided 
by the National Institutes of Health (NIH) in 1980 and the International League 
Against Epilepsy (ILAE) in 1993,FS refers to a seizure that occurs following an 
increase in body temperature(typically over 38°C). In addition, these patients have 
no central system infection or electrolyte imbalance (2–5). Epilepsy is considered 
present when 2 or more unprovoked seizures occur at an interval greater than 
24h apart. The cumulative lifetime incidence of epilepsy is 3% with more than 
half of cases beginning in childhood. Epileptic children have no fever or central 
nervous system infection (6–9).Despite numerous studies, the actual causes of these 
convulsive disorders remain unknown (10, 11).Interestingly, Guo and Yao reported 
that serum melatonin levels decreased significantly in children with complex FS 
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the informed consent form. In all groups, 6 mL of blood 
was drawn from the peripheral vessels and centrifuged. 
The serum was then poured into an acid-washed tube 
and kept in the refrigerator at a controlled temperature 
(-20°C). All melatonin samples were collected within 
24 h after clinical seizures. All conditions such as 
postural conditions and environmental lighting were 
the same for all groups during blood sampling (15). 
Measurement of serum melatonin was performed by 
enzyme-linked immunosorbent assay (ELISA) with a 
kit (IBL International, Hamburg, Germany, and LotNo.
EME151). To improve accuracy, all samples were 
measured in duplicate.For statistical analysis, analysis 
of variance (ANOVA) was used to compare variables 
between the case and control groups; the Mann-Whitney 
test was used for comparisons of serum melatonin levels. 
SPSS version11.5 was used for data analysis. A P-value 
of <0.05was considered statistically significant.
Ethics
The ethics committee of the research department in the 
Qazvin University of Medical Sciences (Project No. 
232) approved the study. All parents were provided 
information regarding the research method in simple 
language. The children were included in the study after 
their parents agreed and signed the informed consent 
form.
Results
The simple FS group was comprised of 19male patients 
and 18 female patients. The complex FS and epilepsy 
groups were comprised of15 males and 22 females, and 
21 males and 16 females, respectively. In the control 
group, 16patients were male and 21 were female (p = 
0.43). The minimum and maximum ages in the case and 
control groups were 6- and 60-months old, respectively. 
There were no statistically significant differences 
between the groups in terms of age, weight, height, 
head circumference, and body temperature (p>0.05; 
Table 1). The serum melatonin levels of the simple 
and complex FS and epilepsy groups were 2, 2.4, and 
2 pg/ml, respectively. The serum melatonin level of the 
control group was 2.1pg/ml. There were no significant 
differences in serum melatonin levels between patients 
with simple FS (p=0.433), complex FS (p= 0.485), and 
and epilepsy(12).Melatonin is a tryptophan-derived 
hormone that is primarily secreted from the pineal gland 
(13,14).The present study investigates the relationship 
between serum melatonin levels and simple or complex 
FS and epilepsy in children.
Materials & Methods
This case-controlled study was conducted at Qazvin 
Children’s Hospital, affiliated with Qazvin University 
of Medical Sciences (Iran) in 2010. Qazvin Children’s 
Hospital is the only referral hospital for children in 
Qazvin province. Case groups (111 total patients) 
were selected consecutively among children who were 
admitted to the hospital following simple or complex 
FS and epileptic seizures (37 patients per group, 
respectively). The control group was comprised of 37 
febrile children without seizures. The age of all patients 
was 6-months–5-years of age. The Sample size was 
calculated according to the following: 
α=0.05; β=0.01; µ2=23.93 ng/1µ 1=20.72 ng/1; δ1=2.54; 
δ2=2.01 (12). Inclusion criteria for the FS groups were 
as follows: 1) fever ≥38°C; 2) the occurrence of seizures 
meeting the criteria for simple FS(generalized seizure 
and s lasting less than15 min);and 3)the occurrence of 
seizure meeting the complex FS criteria (focal, lasting 
more than15 min, and repeated more than once within 
24h).Epilepsy was considered to be present when 2 or 
more unprovoked seizures occurred at an interval greater 
than 24 hapart (16,7).Patients with central nervous 
system infections (such as meningitis or encephalitis), 
electrolyte imbalances, or neurological deficits were 
excluded. The control group included healthy children 
without seizures who visited the hospital clinic due to 
mild febrile illness without any intervention. Children in 
all groups were matched in terms of age, gender, weight, 
height, head circumference, and fever severity. Weight, 
height, head circumference, and body temperature 
(axillary) were measured according to standard methods 
(6).All patients lived in Qazvin City and were permanent 
residents. The study was approved by the ethical 
committee of the Research Department in the Qazvin 
University of Medical Sciences (Project No.232). 
All parents were provided information regarding the 
research method in simple language. The children were 
included in the study after their parents agreed and signed 
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indicated that melatonin has anticonvulsant properties 
(17). Another study showed that melatonin levels were 
low in patients with nocturnal and diurnal complex 
partial epilepsy relative to controls (18).A separate study 
conducted by Molina-Carballo etal. in 54 children with 
convulsive crisis (febrile and epileptic) showed that 
serum melatonin levels increased during seizure attacks 
and returned to normal values 1 hlater. They further 
concluded that excitation of melatonin generation by 
a convulsive crisis may represent the body’s response 
to seizures and is aimed at achieving homeostasis 
(25).Similar results were found in another pervious 
study (26). However, a study reported by Schapel et 
al. in 30 patients with untreated active epilepsy and 
19healthy controls showed that the excretion rates of 
urinary 6-sulfatoxymelatonin (a hepatic metabolite of 
melatonin) in patients with active epilepsy were greater 
than for healthy controls. They further concluded that 
melatonin generation is increased in untreated patients 
with active epilepsy and has a circadian model with phase 
differences relative to controls (19).In contrast, Rao et al 
reported that during seizures and 2 h afterwards, serum 
melatonin levels did not change and remained within the 
normal limits of healthy populations (27).Furthermore, 
a separate study demonstrated that there were no 
significant differences in salivary melatonin levels 
between FS and epileptic patients relative to control 
individuals. They also concluded that the anticonvulsant 
effect of melatonin in epilepsy and FS is not significant 
(15).However, Fauteck showed that single evening dose 
of 5−10 mg melatonin could reduce the occurrence of 
epileptic attacks in children. This study further suggested 
that melatonin could be a useful antiepileptic drug (28).
The antiepileptic effect of melatonin was confirmed by 
Peled, who indicated that the anticonvulsant proprieties 
of melatonin are due to antioxidant activity, increases of 
brain gamma-aminobutyric acid (GABA) concentration, 
inhibition of calcium influx into neurons, and decreased 
neuronal nitric oxide generation(29).In contrast, another 
study found that the anticonvulsant effect of melatonin 
was negligible, and may sometimes exacerbate seizures 
(30).The present study revealed that there are no 
associations between serum melatonin levels and simple 
or complex FS and epilepsy. It appears that melatonin 
plays no role in these convulsive disorders.
epilepsy (p=0.192) relative to the control individuals. 
Furthermore, there were no significant differences 
observed while comparing the case groups (p>0.05; 
Table2, Figure1).
Discussion
Although several studies regarding the role of the 
numerous risk factors for FS and epilepsy have 
been reported (10,11,16), the actual causes of these 
convulsive disorders remain unknown. Based on the 
role of some antioxidants in FS (11–16), present study 
determines whether another antioxidant, melatonin, 
is involved in FS and afebrile seizures. As far as our 
knowledge and the literature review are concerned, 
studies in this area are limited (11,17,19).Melatonin 
((N-acetyl-5-methoxytryptamine) was first extracted 
from the bovine pineal gland by Aaron Lerner in 1958. 
Melatonin is a major hormone secreted by the pineal 
gland that is synthesized from tryptophan and serotonin 
(20).Although the principal function of melatonin is the 
regulation of circadian rhythms and seasonal responses 
(20). Several studies have described its antioxidant 
properties (21–24).The reported antioxidant activities of 
melatonin include scavenging reactive oxygen specimens 
such as hydroxyl radicals and nitric oxide, inhibition of 
lipid peroxidation, decreased oxidation products such 
as malonealdehyde, increased antioxidative defense 
system enzymes such as copper and zinc superoxide 
dismutases, glutathione peroxidase, and glutathione 
reductase, increased intracellular glutathione levels, 
and inhibition of the peroxidative enzymes such as 
nitric oxide synthase. The authors of these studies 
regarding these mechanisms suggest that the function of 
melatonin’s antioxidant activity is to maintain the health 
of the central nervous system (17,21–24). However, the 
notion of anticonvulsant properties of melatonin are 
controversial. Guo etal. reported that serum melatonin 
levels were decreased in children with epilepsy or 
complex FS. They advised that administration of 
exogenous melatonin might be useful for the treatment 
of epilepsy and FS in children (12).A study reported 
by Bazil etal. in patients with intractable temporal lobe 
epilepsy revealed that salivary melatonin was reduced in 
patients with epilepsy at a baseline relative to controls, 
which increased 3-fold following seizures. This study 
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Age(month) 23.75 ±14.59 31.41±1602 28.21 ± 15.17 24.20±14.46 0.1
Weight(kg) 12.57±2.46 13.22±2.26 13.40±2.40 12.14±2.14 0.09
Height(cm) 84.63±10.05 89.58 ±11.34 87.91±11.35 84.44±10.78 0.07
Head 
circumference(cm)
47.68± 1.93 48.54±2.07 48.22±1.97 47.66 ±1.83 0.1
Temperature°C 38.40± 0.36 38.42± 0.42 38.25± 0.39 0.1







Simple FS (2) 0.43
Complex FS (2.4) 0.48
Epilepsy (2) 0.19
Simple FS (2)
Complex FS (2.4) 0.92
Epilepsy (2) 0.4
Complex FS (2.4) Epilepsy (2) 0.24
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